Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1)/glycogen synthase kinase-3 (GSK-3) inhibitors: Synthesis, biological evaluation and molecular modeling studies - Normandie Université
Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2008

Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1)/glycogen synthase kinase-3 (GSK-3) inhibitors: Synthesis, biological evaluation and molecular modeling studies

Domaines

Chimie organique Chimie analytique Catalyse Chimie thérapeutique

Thierry BESSON  : Connectez-vous pour contacter le contributeur

https://normandie-univ.hal.science/hal-02357774

Soumis le : dimanche 10 novembre 2019-18:38:13

Dernière modification le : vendredi 13 décembre 2024-15:28:53

Consulter sur la plateforme ISTEX

Dates et versions

hal-02357774 , version 1 (10-11-2019)

Identifiants

Citer

Cédric Logé, Alexandra Testard, Valérie Thiéry, Olivier Lozach, Mélina Blairvacq, et al.. Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1)/glycogen synthase kinase-3 (GSK-3) inhibitors: Synthesis, biological evaluation and molecular modeling studies. European Journal of Medicinal Chemistry, 2008, 43 (7), pp.1469-1477. ⟨10.1016/j.ejmech.2007.09.020⟩. ⟨hal-02357774⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-NANTES CNRS COMUE-NORMANDIE UNIV-ROCHELLE SORBONNE-UNIVERSITE SU-SCIENCES IICIMED NANTES-UNIVERSITE SBR
30 Consultations
0 Téléchargements

Altmetric

Partager

More